Updated 6 September 2016. This guidance has been developed to provide advice on the prevention of potential sexual transmission of Zika virus. The primary transmission route of Zika virus is via the Aedes mosquito. However, sexual transmission of Zika virus may also be possible, with limited evidence recorded in a few cases. This is of concern due to an association between Zika virus infection and potential complications, including microcephaly and Guillain-Barré syndrome.

Actualización de las orientaciones provisionales 7 de junio de 2016

Actualização das orientações provisórias 7 de Junho de 2016

Lignes directrices provisoires actualisées 7 juin 2016

Clinician Outreach and Communication Activity (COCA) Call April 12, 2016

For national authorities and health care practitioners

This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States. The algorithm is not intended for clinical management of patients with suspected Zika virus infection. The information is provisional and subject to revision when new information becomes available

When is laboratory testing for Zika Virus infection reasonable? Testing algorithm for patients with and without symptoms.

Für wen ist eine Laboruntersuchung auf eine Zika Virus-Infektion sinnvoll? Diagnostisches Vorgehen bei Patienten mit und ohne Symptomen

aktualisiert am 14.03.2016